InvestorsObserver
×
News Home

Should You Buy Arrowhead Pharmaceuticals Inc (ARWR) Stock?

Wednesday, September 23, 2020 02:13 PM | InvestorsObserver Analysts

Mentioned in this article

Should You Buy Arrowhead Pharmaceuticals Inc (ARWR) Stock?

Arrowhead Pharmaceuticals Inc (ARWR) stock is higher by 60.11% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives ARWR stock a score of 77 out of a possible 100.

That rank is mainly influenced by a long-term technical score of 84. ARWR's rank also includes a short-term technical score of 83. The fundamental score for ARWR is 63. In addition to the average rating from Wall Street analysts, ARWR stock has a mean target price of 66.5. This means analysts expect the stock to gain 47.91% over the next 12 months.

Overall Score - 77
ARWR has an Overall Score of 77. Find out what this means to you and get the rest of the rankings on ARWR!

What's Happening with ARWR Stock Today

Arrowhead Pharmaceuticals Inc (ARWR) stock is higher by 2.65% while the S&P 500 is down -1.22% as of 2:10 PM on Wednesday, Sep 23. ARWR is higher by $1.16 from the previous closing price of $43.80 on volume of 1,069,576 shares. Over the past year the S&P 500 has risen 10.40% while ARWR is higher by 60.11%. ARWR lost -$0.24 per share in the over the last 12 months.

Click Here to get the full Stock Score Report on Arrowhead Pharmaceuticals Inc (ARWR) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App